2023
Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease
Sayed A, Assis D, Silveira M, Deng Y, Ciarleglio M, Gaidos J, Proctor D, Al-Bawardy B. Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease. European Journal Of Gastroenterology & Hepatology 2023, 35: 270-274. PMID: 36708297, DOI: 10.1097/meg.0000000000002510.Peer-Reviewed Original ResearchConceptsPrimary sclerosing cholangitisInflammatory bowel diseasePSC-IBDEndoscopic healingTherapy groupAdvanced therapiesClinical remissionBowel diseaseAcute ascending cholangitisRate of cholangitisSmall bowel involvementThird of patientsAscending cholangitisSclerosing cholangitisAdult patientsBowel involvementSecondary outcomesMedian agePrimary outcomeRetrospective studyHigh riskCholangitisPatientsTherapyLarger study
2020
Identifying IBD Providers’ Knowledge Gaps Using a Prospective Web-based Survey
Malter L, Jain A, Cohen BL, Gaidos JKJ, Axisa L, Butterfield L, Rescola BJ, Sarode S, Ehrlich O, Cheifetz AS. Identifying IBD Providers’ Knowledge Gaps Using a Prospective Web-based Survey. Inflammatory Bowel Diseases 2020, 26: 1445-1450. PMID: 32100018, DOI: 10.1093/ibd/izaa032.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseAdvanced practice providersPractice providersManagement of patientsProspective web-based surveyMajority of providersMental health providersAdvance practice providersUse of biosimilarsGreatest educational needsMedical education hoursIBD knowledgeIBD providersIBD patientsMD/DODrug holidayElderly patientsPregnant patientsPrior malignancyAdult patientsBowel diseaseTreatment landscapePain managementColitis FoundationTherapy decisions
2019
Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy
Feagins LA, Kim J, Chandrakumaran A, Gandle C, Naik KH, Cipher DJ, Hou JK, Yao MD, Gaidos JKJ. Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy. Inflammatory Bowel Diseases 2019, 26: 728-733. PMID: 31412114, DOI: 10.1093/ibd/izz175.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseFlare of IBDProstate cancerIBD patientsRadiation treatmentCancer diagnosisRadiation therapyRates of IBDInflammatory bowel disease flaresMultiple logistic regression analysisConcomitant prostate cancerVeterans Affairs hospital systemCharlson Comorbidity IndexRetrospective cohort studyRadiation-treated patientsExternal beam radiationBest treatment approachProstate cancer stageLogistic regression analysisProstate cancer diagnosisDisease flareIBD characteristicsComorbidity indexCohort studyBowel disease
2018
Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record System
Valluru N, Kang L, Gaidos JKJ. Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record System. Digestive Diseases And Sciences 2018, 63: 1782-1786. PMID: 29736836, DOI: 10.1007/s10620-018-5093-5.Peer-Reviewed Original ResearchConceptsPreventive care measuresComputerized patient record systemCare measuresIBD patientsMedication usePreventive carePatient record systemBackgroundInflammatory bowel diseaseImmunosuppressive medication useRetrospective chart reviewRecord systemHPV vaccinationIBD careChart reviewIBD populationBowel diseasePreventable complicationsProvider documentationClinic notesPhysician performance measuresAimThe aimProvider compliancePatientsDemographic dataMcNemar test
2017
Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease
Feagins LA, Waljee A, Hou JK, Gu P, Kanjo S, Rudrapatna V, Cipher DJ, Govani S, Gaidos J. Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2017, 23: 1434-1439. PMID: 28570429, DOI: 10.1097/mib.0000000000001145.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseBiological therapyAdverse drug reactionsConcomitant thiopurinesPrimary nonresponseEarly discontinuationBowel diseaseDrug reactionsDiagnosis of IBDBiological agentsFirst biological agentRetrospective cohort studyInitiation of therapyCourse of therapyVA hospital systemIleocolonic diseaseVA cohortCohort studyVeteran patientsMedical recordsRisk factorsCommon reasonPatientsDiscontinuationTherapy
2016
Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients
Alsaleh A, Gaidos JK, Kang L, Kuemmerle JF. Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients. Digestive Diseases And Sciences 2016, 61: 2602-2607. PMID: 27126205, PMCID: PMC4982818, DOI: 10.1007/s10620-016-4171-9.Peer-Reviewed Original ResearchMeSH KeywordsAbdominal AbscessAdolescentAdultAnastomotic LeakChildColitis, UlcerativeCrohn DiseaseDigestive System Surgical ProceduresFemaleGastrointestinal AgentsHumansIleusInflammatory Bowel DiseasesInfliximabIntestinal ObstructionMaleMiddle AgedPostoperative ComplicationsPreoperative CareReoperationRetrospective StudiesRisk FactorsSurgical Wound InfectionTime FactorsVenous ThromboembolismYoung AdultConceptsLast preoperative dosePostoperative complicationsInflammatory bowel diseasePreoperative doseLast doseUlcerative colitisCrohn's diseaseInflammatory bowel disease patientsMethodsRetrospective chart reviewBowel disease patientsResultsNo significant associationIBD patientsPreoperative statusChart reviewPreoperative useBackgroundThe associationBowel diseaseSurgeon typeSurgery typeSteroid useDisease patientsInfliximabComplicationsPatientsDisease type
2012
Prospective evaluation of the long-term outcomes after deep small-bowel spiral enteroscopy in patients with obscure GI bleeding
Williamson JB, Judah JR, Gaidos JK, Collins DP, Wagh MS, Chauhan SS, Zoeb S, Buscaglia JM, Yan H, Hou W, Draganov PV. Prospective evaluation of the long-term outcomes after deep small-bowel spiral enteroscopy in patients with obscure GI bleeding. Gastrointestinal Endoscopy 2012, 76: 771-778. PMID: 22771101, DOI: 10.1016/j.gie.2012.05.025.Peer-Reviewed Original ResearchConceptsObscure GI bleedingBlood transfusion requirementsGI bleedingLong-term followAdditional therapeutic proceduresTransfusion requirementsSpiral enteroscopyIron supplementationHemoglobin valuesTherapeutic proceduresLong-term clinical outcomesOvert GI bleedingProspective cohort studySingle-center studyAcademic referral centerLong-term outcomesMean hemoglobin valuesSerum hemoglobin valuesOvert bleedingAdverse eventsCohort studyReferral centerClinical outcomesProspective evaluationTherapeutic maneuvers
2011
Retrograde spiral enteroscopy: feasibility, success, and safety in a series of 22 patients
Nagula S, Gaidos J, Draganov PV, Bucobo JC, Cho B, Hernandez Y, Buscaglia JM. Retrograde spiral enteroscopy: feasibility, success, and safety in a series of 22 patients. Gastrointestinal Endoscopy 2011, 74: 699-702. PMID: 21762908, DOI: 10.1016/j.gie.2011.05.017.Peer-Reviewed Original Research
2010
Prospective Evaluation of Gastroenterologist-Guided, Nurse-Administered Standard Sedation for Spiral Deep Small Bowel Enteroscopy
Judah JR, Collins D, Gaidos JK, Hou W, Forsmark CE, Draganov PV. Prospective Evaluation of Gastroenterologist-Guided, Nurse-Administered Standard Sedation for Spiral Deep Small Bowel Enteroscopy. Digestive Diseases And Sciences 2010, 55: 2584-2591. PMID: 20632098, DOI: 10.1007/s10620-010-1335-x.Peer-Reviewed Original ResearchConceptsSmall bowel enteroscopyDeep small bowel enteroscopyDeep enteroscopyStandard sedationMethodsThis prospective case seriesLigament of TreitzProspective case seriesMean insertion depthTotal procedure timePresence of adhesionsSpiral overtubeMinor complicationsConsecutive patientsPatient characteristicsSedation groupCase seriesProspective evaluationFrequent findingEnteroscopyProcedure timeSedationPatientsPositive findingsAmerican SocietyAnesthesiologists
2008
A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis
Gaidos JK, Hillner BE, Sanyal AJ. A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis. Liver International 2008, 28: 650-658. PMID: 18331241, DOI: 10.1111/j.1478-3231.2008.01693.x.Peer-Reviewed Original ResearchConceptsNonalcoholic fatty liver diseaseLiver biopsyLiver diseasePrevalence of NAFLDEarly liver biopsyPrevalent clinical syndromeTransplant-eligible patientsAdvanced liver diseaseInitial liver biopsyFatty liver diseaseSeverity of diseaseCryptogenic cirrhosisEligible patientsEarly biopsyLiver histologyDecision analysis studiesNonalcoholic steatohepatitisSurgical interventionClinical syndromeEarly treatmentStudy groupLB groupMortality rateBiopsy categoriesLower mortality